Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

CEO

Dr. Iraj Ali Ph.D.

Karyawan

204

Negara

Britania Raya

ISIN

US00449L1026

Pencatatan

698.MU

STU

698.STU

0 Comments

Bagikan pendapatmu

FAQ

Berapa harga saham Achilles Therapeutics hari ini?▼

Harga saat ini dari 698.MU adalah €1.36 EUR — naik sebesar +0% dalam 24 jam terakhir. Pantau kinerja harga saham Achilles Therapeutics lebih dekat di grafik.

Apa simbol saham Achilles Therapeutics?▼

Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Achilles Therapeutics diperdagangkan dengan simbol 698.MU.

Berapa jumlah karyawan Achilles Therapeutics?▼

Per Mei 11, 2026, perusahaan memiliki 204 karyawan.

Achilles Therapeutics berada di sektor apa?▼

Achilles Therapeutics beroperasi di sektor Lainnya.

Kapan Achilles Therapeutics menyelesaikan split saham?▼

Achilles Therapeutics belum melakukan split saham baru-baru ini.

Di mana kantor pusat Achilles Therapeutics?▼

Kantor pusat Achilles Therapeutics berlokasi di London, Britania Raya.